Bol Inf Farmacoter Navar. 2023;31 (2):1-22
https://doi.org/10.54095/BITN20233102EN
Table 14 Safety and dose adjustment for cardiovascular system drugs in patients with cirrhosis.
Author:
ANDREA RODRÍGUEZ ESQUÍROZ
Medicines Advice and Information Service
Navarre Health Service